Private company

Principia Biopharma (United States)

Logo: principiabio.com3

Principia Biopharma (United States) is an American pharmaceutical preparations company based in South San Francisco.1 It was founded in 2008.1

Last updated Oct 20, 2026.

Overview

2008Founded1
  • IndustryPharmaceutical Preparations1
  • HeadquartersSouth San Francisco1
  • Websitewww.principiabio.com
  • Incorporated inDE4
  • Business address220 East Grand Avenue, South San Francisco, Ca 940804
  • Filer category, Emerging growth company4

See how the biggest companies compare on our leaderboards

Principia Biopharma (United States) image from its website
Image: principiabio.com3

What it owns

What Principia Biopharma (United States) reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$12.2M5 Dec 31, 2019$3.8M5 Dec 31, 2018+218.6%
Accumulated depreciation$2.5M5 Dec 31, 2019$2.2M5 Dec 31, 2018+15.2%
Property and equipment, net$9.7M5 Dec 31, 2019$1.7M5 Dec 31, 2018+481.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$39.5M5 Dec 31, 2019$34.5M5 Dec 31, 2018+14.6%
Marketable securities, current$276.0M5 Dec 31, 2019$142.4M5 Dec 31, 2018+93.8%
Marketable securities, non-current$52.3M5 Dec 31, 2019$3.7M5 Dec 31, 2018+1307.8%
Debt securities available for sale$363.2M5 Dec 31, 2019$178.0M5 Dec 31, 2018+104.0%

Leadership

Who has led Principia Biopharma (United States), and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Martin Babler2018–2020

President

  1. Martin Babler2019–2020

Chief financial officer

  1. Christopher Y. Chai2018–2020
2010201520202025
Board members and other officers (16)

Timeline

  1. Sep 13, 2018New chief executive Martin Babler becomes CEO6
  2. 2008Founded Founded1

SEC filer profile

How Principia Biopharma (United States) is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARPrincipia Biopharma Inc.2
  • CIK0001510487
  • Employer ID (EIN)26-34876032
  • Filer status<br>emerging growth company2
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Industry code (SIC)2834 Pharmaceutical Preparations2
  • Business address220 East Grand Avenue, South San Francisco, CA 940802
  • Phone(650) 416-77002
  • Shares outstanding33,208,537 as of Jul 31, 202024
  • Public float$540.0M as of Jun 30, 20195
  • On EDGAR sinceFeb 23, 20112
  • Filings242 in all: 4 (83), 8-K (36), 3 (25), SC 13G (13), SC 13G/A (12), 10-Q (6), CORRESP (6), DRS/A (4)2
    All 39 form types

    SC 14D9/A (4), 4/A (3), D (3), EFFECT (3), S-1/A (3), S-8 (3), S-8 POS (3), SC TO-T/A (3), UPLOAD (3), 10-K (2), 424B5 (2), 5 (2), DEF 14A (2), SC 13D (2), SC 13D/A (2), SC14D9C (2), 15-12B (1), 25-NSE (1), 424B4 (1), 8-A12B (1), CERT (1), CT ORDER (1), DEFA14A (1), DRS (1), DRSLTR (1), POS AM (1), S-1 (1), S-3 (1), SC 14D9 (1), SC TO-C (1), SC TO-T (1)

  • Latest filingsAnnual report (10-K) Mar 10, 2020
    Quarterly report (10-Q) Aug 6, 2020
    Proxy statement (DEF 14A) Apr 24, 2020
    Latest 8-K (8-K) Sep 28, 2020

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24